Carmen Bozic, CMO of Vertex Pharmaceuticals VRTX, has filed 0 purchases and 22 sales on the open market. Over the past 12 months that comes to a net sale of $11.3M. The latest trade was on 06/26.

CB

CB

Carmen Bozic

EVP and CMO

Company

Vertex Pharmaceuticals VRTX

First filing

23/02/03

Trades

50 trades

Buys / sales

0 / 22

12-month net buying

−$11.3M

Last trade

06/26

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	06/26	06/30	596 sh	$482.50	$287,570	−3.7%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	06/18	06/23	1,020 sh	$462.17	$471,413.4	−6.0%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	06/15	06/17	4,062 sh	$450.00	$1,827,900	−19.3%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	06/05	06/09	1,745 sh	$450.00	$785,250	−7.7%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	05/29	06/02	1,974 sh	$450.00	$888,300	−8.0%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	05/15	05/19	1,354 sh	$453.45	$613,971.3	−5.2%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	05/12	05/14	6,988 sh	$450.00	$3,144,600	−21.1%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	03/27	03/31	2,329 sh	$450.95	$1,050,262.55	−6.6%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	03/13	03/17	2,329 sh	$481.79	$1,122,088.91	−6.2%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	02/27	03/03	2,329 sh	$480.31	$1,118,641.99	−5.8%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/08/07	24/08/08	2,280 sh	$476.75	$1,086,990	−8.9%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/07/24	24/07/25	2,280 sh	$488.46	$1,113,688.8	−8.2%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/07/10	24/07/12	2,280 sh	$487.34	$1,111,135.2	−7.6%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/06/26	24/06/28	2,280 sh	$471.72	$1,075,521.6	−7.0%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/06/12	24/06/13	2,280 sh	$478.00	$1,089,840	−6.6%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/05/29	24/05/31	2,280 sh	$445.56	$1,015,876.8	−6.2%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/11/14	23/11/16	5,650 sh	$380.82	$2,151,633	−16.2%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/10/31	23/11/02	5,651 sh	$355.92	$2,011,303.92	−13.9%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/10/17	23/10/19	5,651 sh	$373.25	$2,109,235.75	−12.2%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/10/03	23/10/05	5,651 sh	$345.28	$1,951,177.28	−10.9%